Colon cancer | Page 14 of 16

Genes Offer Researchers a ‘Crystal Ball’ to Help Them Prevent, Diagnose, and Treat Cancer

The science of cancer prevention has advanced to the point where researchers now say they can detect ?cancer genes? in the breath of smokers, and can test the presence of two proteins in men they say will predict development of prostate cancer a decade in advance. All of these novel findings need much more examination, of course, but scientists at the American Association for Cancer Research?s Frontiers in Cancer Prevention Research meeting, say these examples illustrate how it is becoming increasingly possible to use genes and their protein products to help predict and diagnose cancer, as well as choose therapy that offers the most potential for a good result. These researchers will also discuss a test that can pick out patients who have pancreatic cancer – an advance that offers hope the disease can be treated at earlier stages than it is now – and how several unique genes can predict which prostate cancer or lung cancer patients will develop aggressive tumors that need additional treatment. Cancer is a disease of genes, they say, so genes can be employed as a crystal ball to thwart the disease.

Cancer :: Firefighters face increased risk for certain cancers

University of Cincinnati (UC) environmental health researchers have determined that firefighters are significantly more likely to develop four different types of cancer than workers in other fields. Their findings suggest that the protective equipment firefighters have used in the past didn’t do a good job in protecting them against cancer-causing agents they encounter in their profession, the researchers say.

Colorectal Cancer :: Data Available from Two Randomized ERBITUX Studies in Metastatic Colorectal Cancer

ImClone Systems Incorporated (NASDAQ:IMCL) and Bristol-Myers Squibb Company (NYSE:BMY) today announced results from two randomized Phase III trials of ERBITUX(R) (cetuximab) in patients with metastatic colorectal cancer. These are the first large, randomized studies to examine the impact of ERBITUX treatment on overall survival in colon cancer.

Cancer :: Report calls for using heated chemotherapy after colon cancer surgery to optimize patient survival

There is new hope for some of the most seriously ill colon cancer patients today, following the release of a consensus statement by 72 leading oncology surgeons from 14 countries, including the United States. The Peritoneal Surface Malignancy Group (PSMG) has concluded that surgery, followed by heated chemotherapy delivered through the lower abdomen of the patient before leaving the operating room, may significantly increase the life expectancy for patients with Stage IV colorectal cancer.

High Fiber Diet :: High-fiber Diet May Be More Important for Men Than Women

A collaborative effort between the Arizona Cancer Center and the National Cancer Institute (NCI) to understand the influence of diet on recurrence of colorectal adenomas (polyps) a precursor to cancer indicates that a high-fiber diet may be more important for men than women. Although the reason for a sex difference is unknown, researchers suggest that it may be related to hormonal effects or the difference between the sexes in location of polyp formation.

Allergy :: Key enzyme involved in allergic disease identified

A research team has identified a key enzyme responsible for triggering a chain of events that results in allergic reaction, according to new study findings published this week in Nature Immunology. The work by researchers from Virginia Commonwealth University, the Hospital for Special Surgery and Weill Cornell Medical College in New York sets the stage for development of new strategies and target therapies that control allergic disease – the sixth leading cause of chronic disease in the United States.

Colorectal Cancer :: Red wine helps to reduce risk of colon cancer

A new research presented at the 71st Annual meeting of the American College of Gastroenterology in Las Vegas, says that consumption of red wine reduces the risk of colon cancer substantially. Colon Cancer or colorectal cancer is the third most common form of cancer and is the second lethal, next to the lung cancer, in the western world.

Cancer :: Agencourt genomic services is key collaborator in new study on breast and colon cancer genes

Agencourt Bioscience Corporation, a Beckman Coulter company, has announced that its Genomic Services were integral in a breakthrough Johns Hopkins study on the genetic code for breast and colon cancers. A recent and widely publicized report on that study, published this month in Science Express, was co-authored by James Hartigan, an Agencourt project manager. The research identifies close to 200 mutated genes, now linked to these cancers, most of which were not previously recognized as associated with tumor initiation, growth, spread or control. The study provides an understanding into disease processes and is expected to drive cancer research for years to come.

Cancer :: New angiogenesis finding may help fight cancer growth

A researcher at the University of Wisconsin-Madison School of Medicine and Public Health has discovered a new part of the complicated mechanism that governs the formation of blood vessels, or angiogenesis.

Diet :: Diet and Exercise – The Real Fountains of Youth

You can take every pill and rue your parents for passing on their genes, but if you want to live long and well there are two things you must do — eat right and exercise.